DexCom Inc. DXCM
Health Care · Health Care Equipment & Services · NASDAQ · United States · dexcom.com
DexCom, Inc. is a U.S. medical device company focused on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for people living with diabetes. Headquartered in San Diego, California, DexCom's CGM systems enable real-time glucose data display and alerts without routine fingersticks, improving diabetes management outcomes.
Key ratios
FreeCashFlowOnSale TTM 0.23
FreeCashFlowOnSale 2025 0.23
FreeCashFlowOnSale 2024 0.16
FreeCashFlowOnSale 2023 0.14
NetIncomeMargin TTM 0.18
NetIncomeMargin 2025 0.18
NetIncomeMargin 2024 0.14
NetIncomeMargin 2023 0.15
ReturnOnAssets TTM 0.09
ReturnOnAssets 2025 0.09
ReturnOnAssets 2024 0.06
ReturnOnAssets 2023 0.06
ReturnOnEquity TTM 0.35
ReturnOnEquity 2025 0.35
ReturnOnEquity 2024 0.28
ReturnOnEquity 2023 0.26
Recent news
Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for People with Type 2 Diabetes Not Using Insulin
2026-06-06 · Business Wire
Dexcom Reaffirms CGM Benefits for All People With Diabetes and Continues Momentum Toward Earlier Stage Intervention and Preventative Care at ADA 2026
2026-06-04 · Business Wire
Dexcom Reports First Quarter 2026 Financial Results
2026-04-30 · Business Wire